BCYC

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Bicycle Therapeutics Ltd

NASDAQ | BCYC

8.57

USD

(

+0.00%

)

At Close (As of Jan 1, 1970)

$545.49M

Market Cap

-

P/E Ratio

-3.75

EPS

$27.70

52 Week High

$6.10

52 Week Low

HEALTHCARE

Sector

BCYC Chart

Recent Chart
Price Action

BCYC Technicals

Tags:

BCYC Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$138M
Total Revenue $35M
Cost Of Revenue $173M
Costof Goods And Services Sold $173M
Operating Income -$210M
Selling General And Administrative $71M
Research And Development $173M
Operating Expenses $72M
Investment Income Net -
Net Interest Income $33M
Interest Income $34M
Interest Expense $1.7M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $7.2M
Income Before Tax -$174M
Income Tax Expense -$4.8M
Interest And Debt Expense -
Net Income From Continuing Operations -$169M
Comprehensive Income Net Of Tax -
Ebit -$172M
Ebitda -$165M
Net Income -$169M

Revenue & Profitability

Earnings Performance

BCYC Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $957M
Total Current Assets $929M
Cash And Cash Equivalents At Carrying Value $880M
Cash And Short Term Investments $880M
Inventory -
Current Net Receivables $36M
Total Non Current Assets $28M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $13M
Other Non Current Assets -
Total Liabilities $164M
Total Current Liabilities $67M
Current Accounts Payable $16M
Deferred Revenue -
Current Debt -
Short Term Debt $11M
Total Non Current Liabilities $97M
Capital Lease Obligations $9.5M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $9.5M
Other Current Liabilities $30M
Other Non Current Liabilities $1.1M
Total Shareholder Equity $793M
Treasury Stock -
Retained Earnings -$681M
Common Stock $890K
Common Stock Shares Outstanding $58M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$165M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $7.2M
Capital Expenditures $1.2M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$1.2M
Cashflow From Financing $520M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$169M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$138M
Total Revenue $35M
Cost Of Revenue $173M
Costof Goods And Services Sold $173M
Operating Income -$210M
Selling General And Administrative $71M
Research And Development $173M
Operating Expenses $72M
Investment Income Net -
Net Interest Income $33M
Interest Income $34M
Interest Expense $1.7M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $7.2M
Income Before Tax -$174M
Income Tax Expense -$4.8M
Interest And Debt Expense -
Net Income From Continuing Operations -$169M
Comprehensive Income Net Of Tax -
Ebit -$172M
Ebitda -$165M
Net Income -$169M

BCYC Profile

Bicycle Therapeutics Ltd Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Bicycle Therapeutics Ltd (BCYC) is an innovative clinical-stage biopharmaceutical company headquartered in Cambridge, UK, specializing in the development of novel therapeutics utilizing its proprietary bicyclic peptide platform. Targeting significant unmet medical needs across various disease areas, particularly in oncology, Bicycle aims to revolutionize treatment modalities with its distinct approach to drug design. The company boasts a robust pipeline of candidates, underscoring its commitment to advancing therapeutic solutions that could redefine standard care for patients facing complex health challenges. As it progresses through clinical trials, Bicycle Therapeutics is well-positioned to make a substantial impact in the biopharmaceutical landscape.

VHAI
-20.00%
$0.00
VIVK
-1.72%
$0.28
YYAI
-10.71%
$0.12
BURU
-17.95%
$0.33
RXRX
-6.33%
$6.36
EPWK
+26.46%
$0.09
BITF
-18.39%
$5.28
IVF
+85.67%
$1.40
NAYA
+85.67%
$1.40
CGBS
-39.47%
$0.03
NVDA
+1.10%
$181.81
PLUG
-8.70%
$3.51
YDKG
-49.73%
$0.09
ADAP
+6.02%
$0.19
BYND
-22.39%
$0.52
NVTS
+3.10%
$15.63
RGTI
-14.85%
$47.97
DNN
-2.83%
$3.08
NIO
-1.09%
$6.74
MIRA
+36.36%
$1.80
SCNX
-17.63%
$0.58
F
-0.17%
$11.74
BBD
+1.71%
$3.25
AADI
+24.28%
$2.61
KVUE
-13.22%
$14.11
ACHR
-8.90%
$11.87
INTC
-0.83%
$36.84
TLRY
-8.33%
$1.54
HPE
-10.06%
$22.52
FEMY
+35.37%
$0.74
TSLA
-1.47%
$428.75
IONZ
+19.44%
$3.44
ONDS
-13.77%
$8.19
CAN
-14.79%
$1.67
AMD
-1.69%
$234.56
DFLI
-32.48%
$1.33
SOFI
+0.57%
$28.03
AXDX
-61.36%
$0.03
ETHD
+6.47%
$3.78
RIG
-2.56%
$3.22
AAL
-4.88%
$11.89
CLF
-2.79%
$13.56
MARA
-11.27%
$20.26
GDXD
-10.23%
$0.60
LAES
-15.08%
$6.36
AMC
-2.30%
$2.75
BTBT
-9.11%
$3.69
RF
-5.61%
$23.35
GNPX
-43.39%
$0.47
QBTS
-9.64%
$40.46
BTG
+3.96%
$5.89
QS
-13.41%
$15.45
VSEE
-13.85%
$0.51
RR
-7.95%
$5.67
GPUS
-5.78%
$0.36
LGCB
+19.39%
$1.97
ABAT
-36.64%
$5.67
NAK
-4.34%
$2.64
SNAP
-1.89%
$7.76
QUBT
-11.72%
$18.73
QSI
-3.42%
$2.54
CIFR
-10.98%
$18.72
RGTZ
+29.08%
$11.23
WOK
+1.55%
$0.05
CRML
-14.52%
$19.42
UUUU
-13.20%
$21.69
IREN
-9.04%
$61.83
ASST
-6.24%
$0.90
PFE
-0.65%
$24.23
MASK
+17.35%
$0.57
KEY
-5.35%
$16.78
HBAN
-5.00%
$15.39
T
+0.49%
$26.20
PLTR
-0.83%
$178.12
SOUN
-2.99%
$20.76
AMZN
-0.51%
$214.47
MU
+5.51%
$202.53
JBLU
-3.63%
$4.76
CLSK
-13.92%
$19.97
APLD
-2.96%
$36.64
SMR
-10.87%
$47.62
FNB
-7.21%
$14.65
WTO
-88.87%
$0.13
RMBL
+60.50%
$3.21
GRAB
-3.54%
$5.71
AAPL
-0.75%
$247.45
WULF
-10.40%
$13.86
NOK
+0.35%
$5.67
ADD
-25.47%
$0.05
SOND
+79.34%
$1.65
AUUD
+0.97%
$2.06
BAC
-4.03%
$50.17
JOBY
-8.69%
$16.07
SLNH
-2.33%
$4.19
IONQ
-9.41%
$65.59
TOVX
-48.34%
$0.43
NEHC
+9.12%
$3.35
SRM
+53.27%
$10.30
SATL
-29.71%
$2.91
BMNR
-5.05%
$51.08
VHAI
-20.00%
$0.00
VIVK
-1.72%
$0.28
YYAI
-10.71%
$0.12
BURU
-17.95%
$0.33
RXRX
-6.33%
$6.36
EPWK
+26.46%
$0.09
BITF
-18.39%
$5.28
IVF
+85.67%
$1.40
NAYA
+85.67%
$1.40
CGBS
-39.47%
$0.03
NVDA
+1.10%
$181.81
PLUG
-8.70%
$3.51
YDKG
-49.73%
$0.09
ADAP
+6.02%
$0.19
BYND
-22.39%
$0.52
NVTS
+3.10%
$15.63
RGTI
-14.85%
$47.97
DNN
-2.83%
$3.08
NIO
-1.09%
$6.74
MIRA
+36.36%
$1.80
SCNX
-17.63%
$0.58
F
-0.17%
$11.74
BBD
+1.71%
$3.25
AADI
+24.28%
$2.61
KVUE
-13.22%
$14.11
ACHR
-8.90%
$11.87
INTC
-0.83%
$36.84
TLRY
-8.33%
$1.54
HPE
-10.06%
$22.52
FEMY
+35.37%
$0.74
TSLA
-1.47%
$428.75
IONZ
+19.44%
$3.44
ONDS
-13.77%
$8.19
CAN
-14.79%
$1.67
AMD
-1.69%
$234.56
DFLI
-32.48%
$1.33
SOFI
+0.57%
$28.03
AXDX
-61.36%
$0.03
ETHD
+6.47%
$3.78
RIG
-2.56%
$3.22
AAL
-4.88%
$11.89
CLF
-2.79%
$13.56
MARA
-11.27%
$20.26
GDXD
-10.23%
$0.60
LAES
-15.08%
$6.36
AMC
-2.30%
$2.75
BTBT
-9.11%
$3.69
RF
-5.61%
$23.35
GNPX
-43.39%
$0.47
QBTS
-9.64%
$40.46
BTG
+3.96%
$5.89
QS
-13.41%
$15.45
VSEE
-13.85%
$0.51
RR
-7.95%
$5.67
GPUS
-5.78%
$0.36
LGCB
+19.39%
$1.97
ABAT
-36.64%
$5.67
NAK
-4.34%
$2.64
SNAP
-1.89%
$7.76
QUBT
-11.72%
$18.73
QSI
-3.42%
$2.54
CIFR
-10.98%
$18.72
RGTZ
+29.08%
$11.23
WOK
+1.55%
$0.05
CRML
-14.52%
$19.42
UUUU
-13.20%
$21.69
IREN
-9.04%
$61.83
ASST
-6.24%
$0.90
PFE
-0.65%
$24.23
MASK
+17.35%
$0.57
KEY
-5.35%
$16.78
HBAN
-5.00%
$15.39
T
+0.49%
$26.20
PLTR
-0.83%
$178.12
SOUN
-2.99%
$20.76
AMZN
-0.51%
$214.47
MU
+5.51%
$202.53
JBLU
-3.63%
$4.76
CLSK
-13.92%
$19.97
APLD
-2.96%
$36.64
SMR
-10.87%
$47.62
FNB
-7.21%
$14.65
WTO
-88.87%
$0.13
RMBL
+60.50%
$3.21
GRAB
-3.54%
$5.71
AAPL
-0.75%
$247.45
WULF
-10.40%
$13.86
NOK
+0.35%
$5.67
ADD
-25.47%
$0.05
SOND
+79.34%
$1.65
AUUD
+0.97%
$2.06
BAC
-4.03%
$50.17
JOBY
-8.69%
$16.07
SLNH
-2.33%
$4.19
IONQ
-9.41%
$65.59
TOVX
-48.34%
$0.43
NEHC
+9.12%
$3.35
SRM
+53.27%
$10.30
SATL
-29.71%
$2.91
BMNR
-5.05%
$51.08
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.